Future of drugs-Diabetes

Drug Name	Luseogliflozin
Structure
Drug Code	TS-071
Synonym	(2S,3R,4R,5S,6R)-2-[5-(4-Ethoxybenzyl)-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol
Molecular Formula	C₂₃H₃₀O₆S
Innovator	Taisho Toyama Pharmaceutical Novartis for marketing
Condition	Type-2 diabetes mellitus
Mechanism of Action	Sodium-glucose transporter 2 inhibitor
Clinical Phase	I
Approval	Approved in Japan in March 2014.

PHARMA LITERATI